© 2026 Sinochem Nanjing Corporation,
All Right Reserved
People working with pharmaceuticals and chemicals come across Bromocriptine Mesylate frequently, particularly in medical research and production settings. This compound goes by many names and numbers, but its chemical identity boils down to the formula C32H40BrN5O5 · CH4O3S. Bromocriptine comes from ergot alkaloids, and features a complex structure including bromide and mesylate groups. Physically, it usually shows up as a white to off-white crystalline powder. Its texture may feel grainy and slightly slippery to the touch depending on the handling environment. This material doesn't smell like much, so nothing harsh will hit the nose during inspection. In laboratories, a quick test with common solvents shows it dissolves best in methanol, ethanol, or chloroform, presenting chemical teams with some latitude for formulation and handling.
Looking deeper at its structural backbone, Bromocriptine Mesylate features a rigid indole base linked to a cyclopeptide ring, which is what chemists check for using spectroscopy and chromatography methods. Its molecular weight lands at 750.70 g/mol—somewhat heavy compared to basic chemicals but not outside the practical range for pharmaceutical-grade active ingredients. The density hovers around 1.4 g/cm³, which means it packs tightly without taking up much space, and makes weighing and compounding tasks more predictable. For lab workers, the solid material refracts light, pointing to its crystalline nature—sometimes forming flakes or solid pearls if stored correctly in sealed containers away from bright light. High purity batches should not show visible discoloration. Physical stability ties closely with temperature and light exposure, where this substance begins to degrade if not kept in dark, dry conditions between 2°C and 8°C. Water barely dissolves it, so there’s little risk of accidental solution during ordinary handling.
Manufacturers and importers navigate a maze of codes and names. The internationally recognized HS Code for Bromocriptine Mesylate is 2934999099, which ties to pharmaceutical raw materials. Customs documentation falls under this number, certifying shipments for legal import and export. Beyond standard identifiers, professionals monitor the integrity of each lot using batch numbers, production dates, and molecular property sheets provided by suppliers. Each purchase typically comes with analytical data—HPLC, NMR, or MS—to guarantee no foreign contaminants impact its intended use in drug synthesis or research. While every country prefers its own method for registration and tracking, this HS Code anchors trade and compliance.
Every workplace that deals with Bromocriptine Mesylate trains its staff in safe handling, because this chemical acts both as a therapeutic agent and a compound capable of harm in large or improper doses. Direct contact with skin or inhalation of powder triggers irritation for sensitive people. Proper gear, such as gloves and safety glasses, belongs on anyone handling the raw material in its crystalline, flaked, or powdered forms. Ingestion demands immediate medical attention, as high doses can interfere with dopamine function, potentially leading to acute poisoning. Storage recommendations remain strict: keep dry, avoid sunlight, use airtight vessels, and ensure access is restricted to qualified personnel. Clearing up accidental spills uses absorbent material and well-ventilated spaces, then disposing of everything following hazardous waste protocols. This practical approach—one I’ve seen enforced in lab environments—keeps workers and the environment safe from unintended exposure or contamination.
In pharmaceutical circles, Bromocriptine Mesylate stands out as a classic example of a raw material whose chemical properties drive its value. Drug manufacturers depend on its reliability in solid and powder states, so they can weigh and press precise doses without wondering about batch-to-batch variability. Even beyond finished medicines, its molecular specificity and stable density let formulation chemists explore modified-release drugs or test interactions with other actives or excipients. Researchers leverage its well-characterized structure to investigate dopamine-related disorders—not just in pills, but in solutions where precise dosing tests pharmacokinetics. For those developing regulatory filings or supporting clinical trials, each lot’s traceability straight back to its manufacturing source matters just as much as its technical properties. This blend of science and logistics shapes the practical value of Bromocriptine Mesylate and underscores how chemical knowledge intertwines with broader health and safety frameworks.
A raw material with medical uses always brings both promise and risk to the table. Unintentional exposure can cause harmful health effects, making robust safety protocols essential. Counterfeit supply chains put patients at risk and expose companies to penalties, so verifying product origin, structure, and chemical purity must anchor any procurement plan. I’ve seen firsthand how cutting corners—failing to check expiry dates, storing in damp conditions, skipping protective gear—sets the stage for accidents or long-term damage. Regulatory bodies demand traceability for exactly these reasons. Collaborating across the supply and regulatory landscape could address gaps in quality, which protects everyone downstream, from manufacturing workers to patients. Doubling down on real-time monitoring, periodic supplier audits, and chemical verification tools like rapid spectrometry reduces the risk of contamination or mislabeling. Everyone handling Bromocriptine Mesylate—whether in bulk raw powder, pearlescent flakes, or as a lab solution—shares responsibility for making sure every step keeps safety, quality, and human health in focus.
